Plasma interleukin-18 levels in patients with psychiatric disorders

J Immunother. 2002 Mar-Apr:25 Suppl 1:S68-71. doi: 10.1097/00002371-200203001-00011.

Abstract

There are an increasing number of reports on an association between the alteration of circulating cytokine levels and pathophysiology of psychiatric disorders. Plasma concentrations of interleukin (IL)-18 were measured in 13 nonmedicated patients with psychiatric disorders. There was a significant elevation of IL-18 levels in patients with major depression (n = 8) and panic disorder (n = 5), compared with normal controls. The mean IL-18 value of our psychiatric patients was comparable with that of various somatic disorders reported. We suggest that the elevation of plasma IL-18 levels reflects the increased production and release of IL-18 in the central nervous system under stressful settings. We propose that the measurement of IL-18 plasma levels may provide a useful index for the involvement of immune system in psychiatric disorders.

MeSH terms

  • Adult
  • Biomarkers / analysis
  • Case-Control Studies
  • Depressive Disorder / blood
  • Depressive Disorder / physiopathology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Interleukin-18 / blood*
  • Interleukin-18 / metabolism
  • Male
  • Mental Disorders / blood*
  • Mental Disorders / physiopathology*
  • Middle Aged
  • Panic Disorder / blood
  • Panic Disorder / physiopathology
  • Probability
  • Prognosis
  • Reference Values
  • Sampling Studies
  • Sensitivity and Specificity

Substances

  • Biomarkers
  • Interleukin-18